Evidence map›Paper›PMID 11967288›Full record

ArticleJournal of virology2002

Human immunodeficiency virus type 1 uses lipid raft-colocalized CD4 and chemokine receptors for productive entry into CD4(+) T cells.

Waldemar Popik, Timothy M Alce, Wei-Chun Au

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 169 papers.

0numbers the graph read from it
0cells of the map it votes in
169citing papers in PubMed
9.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

169 citing papers in PubMed, 322 citations in OpenAlex.

  1. Article
  2. Review
  3. Novel Wide-Spectrum Virucidal Lipid Nanoparticles.Small (Weinheim an der Bergstrasse, Germany) · 2026
    Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Neutral sphingomyelinase 2 is required for HIV-1 maturation.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

109 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Waldemar PopikOncology Center, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21231, USA. wpopik@jhmi.edu
Timothy M Alce
Wei-Chun Au
Johns Hopkins Medicine · USJohns Hopkins University · US

Funding

ROLE OF LIPID RAFTS IN HIV-1 ENTRYR01AI050461 · NIAID · JOHNS HOPKINS UNIVERSITY · PI POPIK, WALDEMAR · 2002 to 2005
$838k
ROLE OF LIPID RAFTS IN HIV-1 ENTRYR21AI050461 · NIAID · JOHNS HOPKINS UNIVERSITY · PI POPIK, WALDEMAR · 2001 to 2001
$245k
NIAID NIH HHS AI42557NIAID NIH HHS AI50461NIAID NIH HHS R01 AI050461NIAID NIH HHS R21 AI050461NIMHD NIH HHS L60 MD003100
6 · The paper itself

Abstract

In this report, we describe a crucial role of lipid raft-colocalized receptors in the entry of human immunodeficiency virus type 1 (HIV-1) into CD4(+) T cells. We show that biochemically isolated detergent-resistant fractions have characteristics of lipid rafts. Lipid raft integrity was required for productive HIV-1 entry as determined by (i) semiquantitative PCR analysis and (ii) single-cycle infectivity assay using HIV-1 expressing the luciferase reporter gene and pseudotyped with HIV-1 HXB2 envelope or vesicular stomatitis virus envelope glycoprotein (VSV-G). Depletion of plasma membrane cholesterol with methyl-beta-cyclodextrin (MbetaCD) relocalized raft-resident markers to a nonraft environment but did not significantly change the surface expression of HIV-1 receptors. MbetaCD treatment inhibited productive infection of HIV-1 by 95% as determined by luciferase activity in cells infected with HXB2 envelope-pseudotyped virus. In contrast, infection with VSV-G-pseudotyped virus, which enters the cells through an endocytic pathway, was not suppressed. Biochemical fractionation and confocal imaging of HIV-1 receptor distribution in live cells demonstrated that CD4, CCR5, and CXCR4 colocalized with raft-resident markers, ganglioside GM1, and glycosylphosphatidylinositol-anchored CD48. While confocal microscopy analysis revealed that HIV-1 receptors localized most likely to the same lipid microdomains, sucrose gradient analysis of the receptor localization showed that, in contrast to CD4 and CCR5, CXCR4 was associated preferentially with the nonraft membrane fraction. The binding of HIV-1 envelope gp120 to lipid rafts in the presence, but not in the absence, of cholesterol strongly supports our hypothesis that raft-colocalized receptors are directly involved in virus entry. Dramatic changes in lipid raft and HIV-1 receptor redistribution were observed upon binding of HIV-1 NL4-3 to PM1 T cells. Colocalization of CCR5 with GM1 and gp120 upon engagement of CD4 and CXCR4 by HIV-1 further supports our observation that HIV-1 receptors localize to the same lipid rafts in PM1 T cells.

Indexed as

beta-CyclodextrinsCD4 AntigensCD4-Positive T-LymphocytesCell LineCholesterolCyclodextrinsG(M1) GangliosideHIV-1HIV Envelope Protein gp120HumansJurkat CellsMembrane LipidsMembrane MicrodomainsMicroscopy, ConfocalReceptors, CCR5Receptors, Chemokinebeta-CyclodextrinsCD4 AntigensCholesterolCyclodextrinsG(M1) GangliosideHIV Envelope Protein gp120Membrane Lipidsmethyl-beta-cyclodextrinReceptors, CCR5Receptors, ChemokineReceptors, CXCR4

Identifiers

PMID11967288
PMCPMC136131
OpenAlexW2139171197

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.